What is the target audience for these bi-anual shots? Only populations at high risk or are we supposed to start vaccinating everyone that is sexually active?
Btw, nothing on the article about potential side effects.
>What is the target audience for these bi-annual shots?
In the US, there are certain patients who are at high risk for HIV infection. They are men who have sex with men, intravenous drug users, and people who have sex for money or housing.
In Southern Africa, young women experience some of the highest incidence rates of HIV infection in the world [0], so that would be the high risk population there.
In terms of side effects, there are practically none for the once-every-two-months drug Apretude, which is prescribed in the US for the high risk population I mentioned. They are mostly around the physical injection itself/
That would be up to individuals or health departments, who decide what risk is high enough. The risk for non-promiscuous people in 'western' countries is so low, that I don't see any country giving this to everybody.
This is not a vaccine, BTW, and it needs to be given every 6 months.
Btw, nothing on the article about potential side effects.